EUVIMEDDécouvrir EUVIMED
Open access · CC BY 4.0

First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study

Natalia Starodubtseva, Alisa Tokareva, Alexey Kononikhin, Alexander Brzhozovskiy, Anna Bugrova, Evgenii Kukaev iD, Kamilla Muminova, Alina Nakhabina, Vladimir E Frankevich, Evgeny Nikolaev, Gennady Sukhikh

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910653 ↗

At a glance

Journal article in International Journal of Molecular Sciences, 2024. Written by Natalia Starodubtseva and 10 co-authors. Institution: V.I. Kulakov National Medical Research Center for Obstetrics Gynecology and Perinatology, Ministry of Healthcare of Russian Federation, 117997 Moscow…. Major MEDLINE topics: Pre-Eclampsia, Proteome, Biomarkers, Pregnancy Trimester, First. Cited 1 times so far (Crossref); 89 references. The full text is freely available (open access, CC BY 4.0). Funded by: Russian Science Foundation.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Preeclampsia (PE) is a complex and multifaceted obstetric syndrome characterized by several distinct molecular subtypes. It complicates up to 5% of pregnancies and significantly contributes to maternal and newborn morbidity, thereby diminishing the long-term quality of life for affected women. Due to the widespread dissatisfaction with the effectiveness of existing approaches for assessing PE risk, there is a pressing need for ongoing research to identify newer, more accurate predictors. This study aimed to investigate early changes in the maternal serum proteome and associated signaling pathways. The levels of 125 maternal serum proteins at 11–13 weeks of gestation were quantified using liquid chromatography–multiple reaction monitoring mass spectrometry (LC-MRM MS) with the BAK-125 kit. Ten serum proteins emerged as potential early markers for PE: Apolipoprotein M (APOM), Complement C1q subcomponent subunit B (C1QB), Lysozyme (LYZ), Prothrombin (F2), Albumin (ALB), Zinc-alpha-2-glycoprotein (AZGP1), Tenascin-X (TNXB), Alpha-1-antitrypsin (SERPINA1), Attractin (ATRN), and Apolipoprotein A-IV (APOA4). Notably, nine of these proteins have previously been associated with PE in prior research, underscoring the consistency and reliability of our findings. These proteins play key roles in critical molecular processes, including complement and coagulation cascades, platelet activation, and insulin-like growth factor pathways. To improve the early prediction of PE, a highly effective Support Vector Machine (SVM) model was developed, analyzing 19 maternal serum proteins from the first trimester. This model achieved an area under the curve (AUC) of 0.91, with 87% sensitivity and 95% specificity, and a hazard ratio (HR) of 13.5 (4.6–40.8) with p < 0.001. These findings demonstrate that serum protein-based SVM models possess significantly higher predictive power compared to the routine first-trimester screening test, highlighting their superior utility in the early detection and risk stratification of PE.

Subjects

MeSH terms (MEDLINE)

Pre-EclampsiaProteomeBiomarkersPregnancy Trimester, FirstHumansFemalePregnancyPilot ProjectsAdultProteomicsBlood ProteinsChromatography, Liquid

Author keywords

mass spectrometrypreeclampsiapregnancyprognosisquantitative proteomicsscreeningserum

Substances

ProteomeBiomarkersBlood Proteins

Authors and institutions

  • V.I. Kulakov National Medical Research Center for Obstetrics Gynecology and Perinatology, Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia.
  • Moscow Center for Advanced Studies, 123592 Moscow, Russia.
  • Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia.
  • V.L. Talrose Institute for Energy Problems of Chemical Physics, N.N. Semenov Federal Research Center of Chemical Physics, 119334 Moscow, Russia.
  • Laboratory of Translational Medicine, Siberian State Medical University, 634050 Tomsk, Russia.
  • Independent Researcher, 121205 Moscow, Russia.

ORCID profiles: Evgenii Kukaev

Funding

  • Russian Science Foundation

Cite

APA

Starodubtseva, N., Tokareva, A., Kononikhin, A., Brzhozovskiy, A., Bugrova, A., Kukaev, E., Muminova, K., Nakhabina, A., Frankevich, V. E., Nikolaev, E., & Sukhikh, G. (2024). First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910653

Vancouver

Starodubtseva N, Tokareva A, Kononikhin A, Brzhozovskiy A, Bugrova A, Kukaev E, et al. First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910653

BibTeX
@article{Starodubtseva2024,
  author = {Starodubtseva, Natalia and Tokareva, Alisa and Kononikhin, Alexey and Brzhozovskiy, Alexander and Bugrova, Anna and Kukaev, Evgenii and Muminova, Kamilla and Nakhabina, Alina and Frankevich, Vladimir E and Nikolaev, Evgeny and Sukhikh, Gennady},
  title = {First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910653}
}
Start for free →